Cargando…
Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
Autores principales: | Dong, Huaying, Hu, Jianguo, Zou, Kejian, Ye, Mulin, Chen, Yuanwen, Wu, Chengyi, Chen, Xin, Han, Mingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241177/ https://www.ncbi.nlm.nih.gov/pubmed/35768868 http://dx.doi.org/10.1186/s12943-022-01609-6 |
Ejemplares similares
-
Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2019) -
Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
por: Dong, Huaying, et al.
Publicado: (2021) -
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022) -
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018) -
TINCR: An lncRNA with dual functions in the carcinogenesis process
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2020)